Connect with us

Hi, what are you looking for?

Thursday, May 22, 2025
Mugglehead Investment Magazine
Alternative investment news based in Vancouver, B.C.
Ontario researcher is determining if supplements can lessen risk of radon-linked lung cancer
Ontario researcher is determining if supplements can lessen risk of radon-linked lung cancer
Christopher Thome, PhD, research lead and assistant professor -- NOSM University. Photo credit: LinkedIn

Medical and Pharmaceutical

Researcher wants to know if supplement can lessen risk of radon-linked lung cancer

Him and his team have C$1.7M at their disposal for the next few years to find out

Researchers from the Northern Ontario School of Medicine University are currently assessing whether an antioxidant supplement can help prevent radon-induced lung cancer. They are using mice to find out.

As radon is the second-leading cause of lung cancer in Canadians, the early-stage investigation could eventually provide valuable data and an efficacious preventative tool. About 16 per cent of lung cancer deaths in the country are attributed to the naturally-occurring radioactive gas.

Research lead Christopher Thome and his team have received a C$200,000-dollar grant from the Canadian Cancer Society for their work.

Additionally, the Natural Sciences and Engineering Research Council of Canada committed C$1.5 million over a five-year period in 2023 to help propel their studies.

“Our hypothesis is that by taking this antioxidant dietary supplement at the same time that you’re being exposed to these high levels of radon gas, that we should see a reduction in some of the damage that’s done to the lung tissue,” Thome told the CBC this week.

Read more: Breath Diagnostics now offering a compelling investment opportunity

They are using a ‘first of its kind in Canada’ chamber

The research team’s aim is to make the supplement widely available to protect Canadians, but Thome says they still need to collect more data on the supplement’s impact before that will be possible.

Australian research partners have taught them how to build a special chamber to safely expose rodents to the gas while avoiding any contamination in the lab.

“Our research project could unveil a low-cost, safe and potentially lifesaving mitigation strategy for radon-induced lung cancer,” Thome said last summer.

The Nuclear Innovation Institute in Port Elgin, Cameco Corp (TSE: CCO) (NYSE: CCJ) (FRA: CJ6) and Bruce Power have also contributed undisclosed sums for the studies.

A study led by the University of Calgary last year found that an alarming 18 per cent of Canadian homes had unsafe levels of radon. The gas, produced by uranium decay underground, tends to reside in the basement level of houses.

Read more: Breath Diagnostics gives the public the chance to join the fight against cancer

 

Follow Mugglehead on X

Like Mugglehead on Facebook

Follow Rowan Dunne on X

Follow Rowan Dunne on LinkedIn

rowan@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Medical and Pharmaceutical

The model uses graph neural networks to interpret complex biological interactions

Medical and Pharmaceutical

The Alberta Cancer Foundation is also contributing C$500K

AI and Autonomy

Oracle's agent combines generative AI, agentic technology, automation, multimodal voice, and screen-driven assistance into one solution

Medical and Pharmaceutical

Researchers are working to bring this technology to market